Skip to main content

Inflammatory Bowel Disease and cannabis in West Virginia

The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Listed qualifying condition
✓ Yes
LEGAL
30-day supply as certif…
POSSESSION
$50/yr
STATE FEE
14–45 d
TIMELINE
Listed qualifying condition. The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

West Virginia statute and program

The West Virginia Medical Cannabis Program is the operating authority for West Virginia patient certification. The authoritative legal text is: West Virginia Code Chapter 16A: Medical Cannabis Act. The program portal is at West Virginia Medical Cannabis Program.

What the evidence says about cannabis and Inflammatory Bowel Disease

. Both produce abdominal pain, diarrhea, fatigue, weight loss, and extraintestinal complications. The conditions differ in inflammation pattern: Crohn's can affect any part of the GI tract in patchy distribution, while ulcerative colitis is restricted to the colon in continuous distribution.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Inflammatory Bowel Disease page.

How to qualify in West Virginia

The West Virginia Medical Cannabis Program requires the following registration steps for a Inflammatory Bowel Disease patient (or any qualifying diagnosis):

  1. See a West Virginia-registered medical cannabis physician. Under the West Virginia Medical Cannabis Act (W. Va. Code §16A-1-1 et seq.), a West Virginia-licensed physician who has completed the West Virginia Bureau for Public Health four-hour training course and registered with the West Virginia Office of Medical Cannabis (OMC) must certify the patient. Qualifying conditions include cancer, HIV/AIDS, ALS, Parkinson’s, MS, intractable seizures, sickle-cell anemia, intractable pain, terminal illness, Crohn’s, neuropathies, Huntington’s, PTSD, and severe chronic or intractable pain (§16A-4-3).
  2. Apply through the West Virginia OMC online portal. The patient creates an account in the OMC online registry, uploads a West Virginia driver license or state ID and a passport-style photo, and links the physician’s electronic certification. Caregivers (required for minor patients) register separately and undergo a state and federal criminal background check.
  3. Pay the $50 state registration fee (or qualify for a waiver). The annual West Virginia OMC patient identification card fee is $50, waived for veterans, patients enrolled in the federal Supplemental Nutrition Assistance Program (SNAP), and patients with documented financial hardship under OMC rules. Caregiver registration is also $50 with the same waiver eligibility.
  4. Receive the card and purchase from a West Virginia dispensary. West Virginia OMC patient identification cards are issued within roughly 30 days of complete application. Patients may purchase up to a 30-day supply (forms include pills, oils, topical applications, tinctures, liquids, and dermal patches — no smokable flower under §16A-4-3) from any licensed West Virginia medical cannabis dispensary. West Virginia does not honor out-of-state medical cards.
State registration fee
$50
Physician visit (typical)
$150–$300
Certification to card
14–45 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full West Virginia registration steps, fees, and reciprocity rules, see the West Virginia cannabis-laws page.

ICD-10 code

A certifying physician documenting Inflammatory Bowel Disease for the West Virginia medical cannabis program will typically record ICD-10 K51.90 or SNOMED-CT 24526004 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does West Virginia list Inflammatory Bowel Disease as a qualifying condition for medical cannabis?

Yes. West Virginia explicitly lists Inflammatory Bowel Disease as a qualifying condition under West Virginia Medical Cannabis Program. A patient with a documented Inflammatory Bowel Disease diagnosis can pursue state-program certification with a physician registered in the state. The qualifying-condition list is published by the state at https://omc.wv.gov/ and may change as regulators add, remove, or refine entries. Inclusion on the list does not guarantee certification — a physician still has to evaluate the patient and decide that medical cannabis is appropriate for that specific case under West Virginia rules.

How do I get a West Virginia medical marijuana card for Inflammatory Bowel Disease?

Step one is finding a physician licensed in West Virginia who is registered with West Virginia Medical Cannabis Program and willing to evaluate Inflammatory Bowel Disease cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. West Virginia does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the West Virginia Medical Cannabis Program site at https://omc.wv.gov/; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Inflammatory Bowel Disease?

For Inflammatory Bowel Disease, evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Inflammatory Bowel Disease lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Inflammatory Bowel Disease should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Inflammatory Bowel Disease and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Inflammatory Bowel Disease; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. West Virginia Code Chapter 16A: Medical Cannabis Actaccessed May 16, 2026
  2. West Virginia Office of Medical Cannabis (Bureau for Public Health)accessed May 16, 2026
  3. Wikipedia: Cannabis in West Virginiaaccessed May 16, 2026
  4. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 15, 2026
  5. Crohn's & Colitis Foundationaccessed May 15, 2026